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In This IssueMobile Elements Mobilize Oncogenes
PAGE 101
Shukla et al. show that L1 retrotransposons, common in the human genome, can mobilize and
activate oncogenes in the livers of individuals infected with hepatitis B or C virus, promoting
development of hepatocellular carcinoma. Specifically, insertions in the mutated in colorectal
cancer gene activate oncogenic Wnt signaling, whereas other insertions interrupt a negative
feedback loop regulating the tumor suppressor ST18. These genes present new options
for cancer screening and intervention and suggest that retrotransposon activation may be an
important tumorigenic mechanism.
Oncogenic Translocation Remodels Chromatin
Remodeler
PAGE 71A translocation that fuses the SS18 gene on chromosome 18 to a related gene on X (SSX) is the likely initiating event in human
synovial sarcoma, a soft-tissue malignancy. Kadoch and Crabtree now elucidate the transformation mechanism by showing
that SS18 is a subunit of the chromatin-remodeling complex BAF. The SS18-SSX fusion competes with wild-type SS18, creating
an altered BAF complex that lacks the tumor suppressor BAF47 and hence activates—rather than suppresses—Sox2, driving
proliferation.
Neurotransmitter Signaling Drives Cancer Progression
PAGE 86
Interstitial fluid pressure and glutamate receptors have been independently implicated in tumor progression. Li and Hanahan now
demonstrate that pressure-driven flow conditions activate an autocrine glutamate-to-NMDA receptor (NMDAR) signaling circuit in
cancer cells, involving the CaMK and MEK pathways, thereby enhancing invasiveness and proliferation. Elevated expression of
NMDAR plus glutamate transporters correlates with poor prognosis in certain human cancers, and inhibition of NMDAR signaling
in a mouse model impairs tumor progression.
Lipid Protector Battles Influenza
PAGE 112
There is a need for new and more effective drugs for treating influenza, given the potential for future lethal pandemics. Morita et al.
report that the lipid mediator protectin D1 (PD1) suppresses influenza replication by impeding the nuclear export of viral RNAs.
Administration of PD1 protects mice against the lethal 2009 H1N1 influenza even at later stages of infection when current antiviral
therapies are ineffective.
Antibody Mutations that Are Worth the Wait
PAGE 126
Antibodies typically accumulate somatic hypermutations in the complementarity determining regions (CDR). CDRs are scaffolded
by canonical framework regions (FWRs) that are less tolerant of mutations. Yet, Klein et al. show that FWR mutations play a crucial
role in antibodies with broad and potent HIV-1 neutralization activity (bNAbs). This may explain the long latency period required for
the appearance of bNAbs in HIV-1-infected individuals and should be considered in HIV-1 vaccine design.
Achilles Heel for Glioblastoma in GSC-Derived Vasculature
PAGE 139Glioblastomas are highly vascular, lethal brain tumors that contain tumorigenic self-renewing
glioma stem cells (GSCs). Using in vivo lineage tracing, Cheng et al. now show that GSCs give
rise to vascular pericytes, cells that support blood vessel function. Eliminating GSC-derived peri-
cytes disrupts the neovasculature and inhibits tumor growth, suggesting that targeting of peri-
cytes may be an effective approach that could complement current anti-angiogenic therapies.
Y an RNA Reshapes Enzyme Function
PAGE 166
In animal cells and some bacteria, the Ro protein binds noncoding RNAs of unknown function
called Y RNAs. Chen et al. show that a bacterial Y RNA tethers Ro protein to the exoribonuclease
polynucleotide phosphorylase (PNPase), altering its specificity such that it specializes in breaking
down structured RNAs. This work shows that by tethering a protein cofactor, a noncoding RNA
can alter the substrate specificity of an enzyme.Cell 153, March 28, 2013 ª2013 Elsevier Inc. 1
Mitosis Reshuffles the DNA Deck at the Nuclear Lamina
PAGE 178
The nuclear lamina interacts with hundreds of large genomic regions termed lamina-associated
domains (LADs). Using a newvisualization technique, Kind et al. show that in each nucleus only a third
of LADs are positioned at the periphery and that upon mitosis, LAD positioning is not detectably in-
herited but instead is stochastically reshuffled. In single cells, contact between the nuclear lamina
and individual LADs is linked to transcriptional repression and H3K9 dimethylation.
Prions Foster Budding Friendships
PAGE 153
Holmes et al. show that a prion formed by the Mot3 transcription factor governs the acquisition of
facultativemulticellularity in the budding yeast. The prions were induced by ethanol and eliminated by hypoxia—conditions that occur
sequentially in the natural respiro-fermentative cycles of yeast populations. Their findings demonstrate that prions can act as environ-
mentally responsive molecular determinants of multicellularity and contribute to the natural morphological diversity of budding yeast.
Horses for Courses in DNA Methylation
PAGE 193
DNA methylation regulates genes and transposable elements across eukaryotes. Zemach et al. study the RNA-dependent DNA
methylation (RdDM) pathway and the nucleosome remodeler DDM1, which are both required for DNA methylation in Arabidopsis.
They show that RdDm and DDM1 act separately: DDM1 makes heterochromatic regions bound by linker histone H1 accessible
to methyltransferases, whereas RdDM methylates less heterochromatic regions and relies on a different nucleosome remodeler,
DRD1. The work demonstrates that chromatin structure is a key regulator of DNA methylation.
Speedy Ligase Exchange—Yes, We Cand1!
PAGE 206
SCF complexes comprise a large family of ubiquitin ligases that share core components yet have different substrate receptor
proteins. Combining a real-time FRET assay and quantitative proteomics, Pierce et al. show that Cand1 functions as an exchange
factor for SCF complexes by accelerating their dissociation by one-million-fold. Cand1 thus ensures rapid equilibration of cullin
complexes with a large network of substrate-binding modules.
Golgi Lipids Drive Hypertrophy
PAGE 216
Amajor feature of cardiac remodeling in response to stress is hypertrophic growth. Zhang et al. now show that conditional deletion of
PLCε in mouse cardiac myocytes protects against stress-induced hypertrophy. Surprisingly, PLCε acts on PI4P in the Golgi rather
than the canonical plasmamembrane PLC substrate PIP2. In response to hypertrophic signals, PLCε signaling drives the expression
of hypertrophy genes.
Life-Extending Drug Acts through Microbes
PAGE 228
The drug metformin is widely prescribed to treat type 2 diabetes and can also slow aging in animal models, but its mechanism of
action remains unclear. Cabreiro et al. provide evidence that the life-extending effect of metformin inC. elegans stems from its impact
on host-microbe interactions. Metformin alters microbial folate and methionine metabolism, inducing methionine restriction in the
host, thus slowing aging.
Lifestyle Choice Affected by Diet
PAGE 240
MacNeil et al. show that signals from C. elegan’s bacterial food source affect life-history traits such as developmental rate, repro-
ductive timing, and lifespan. Relative to the standard laboratory diet of E. coli, a diet that includesComamonas bacteria, even in small
amounts, accelerates worm development by altering the larval molting program via a mechanism
that is independent of TOR and insulin signaling but likely involves nuclear hormone receptors. These
findings show how diet can impact lifestyle strategies.
Dietary Response Networks
PAGE 253
Watson et al. use a combination of forward and reverse genetics to identify a network of 184
C. elegans genes that affect its response to a diet of Comamonas bacteria. Many of these genes
encode mitochondrial enzymes involved in amino acid metabolism and the TCA cycle, and many
correspond to genes implicated in inborn errors of metabolism in humans. Furthermore, the results
reveal extensive communication between mitochondrial metabolic networks and nuclear gene
regulatory networks controlling dietary responses.Cell 153, March 28, 2013 ª2013 Elsevier Inc. 3
